Beyond The Script

"We didn't set up a cannabis clinic. We set up a healthcare clinic that used cannabis as a medication." That distinction is everything; in this episode of Beyond the Script, Releaf's CEO Tim Kirby explains what he saw in a broken market, how he built the team and culture behind the UK's largest medical cannabis clinic, and what the job is really about. Tim talks about entering a space dominated by...

Can medical cannabis get you high? Will it show up on a drug test? And what happens if you're a nurse? In Episode 2 of Beyond the Script , Dr. Shereen Rafee, Releaf Consultant & Oncologist, and Rupa Shah, Releaf's Chief Legal and Compliance Officer, tackle the questions patients most want answered. From understanding the real difference between THC and CBD , to knowing your rights at work , dr...

Cannabis as a Medicine: A GP's Honest Experience Featuring: Dr Katherine Fitch, Releaf Consultant & GP Graham Woodward, Chief Medical Officer @ Releaf About This Episode: In this episode of Beyond the Script, our Chief Medical Officer Graham Woodward sits down with Dr Katherine Fitch, a practising GP who also consults at Releaf, to talk about what really changed when she started prescribing me...

EP6 - What does purpose-driven leadership look like inside a fast-growing medical cannabis clinic? In this special edition of the Business of Cannabis Podcast, Tim Kirby, CEO of Releaf, sits down with Professor Chris Shambrook, renowned performance psychologist and long-time advisor to the British Olympic rowing team. Together, they unpack how high-performance principles drawn from elite sport can...

EP5 - Join COO of Releaf, Graham Woodward, and Dr Anne Katrin Schlag, Head of Research at Drug Science, as they explore how the UK can move from anecdotal patient stories to real-world evidence, and why this shift is vital for expanding safe, trusted access to cannabis-based medicines. Let's rethink healTHCare. Chapters: 00:00 Beyond The Script with Anne Schlag 00:19 Meet Anne: Pioneering Med...

EP4 - Tim Kirby, CEO of Releaf and Michael Sassano, CEO and Chairman of the Board with SOMAÍ Pharmaceuticals discuss strategies for expanding the medical cannabis market in the UK. They highlight the challenges in the current market, such as patient accessibility and supply chain issues, emphasise the importance of vertical integration and advanced extraction techniques to ensure product qual...

EP3 - In this special edition episode, Releaf COO Graham Woodward sits down with cannabinoid pharmacologist Professor Saoirse O’Sullivan to explore whether our current approach to cannabis-based treatment is truly evidence-led or built on outdated myths. From the science behind THC and CBD to the truth about the entourage effect, this episode challenges assumptions and asks what it takes to get ca...

EP2 - Robert Jappie, partner at Fieldfisher LLP and Tim Kirby, CEO at Releaf unpack the challenges and opportunities shaping the UK’s medical cannabis landscape, from the slow-moving regulatory environment to the urgent need for patient-focused innovation. Key topics include: - Why the UK's medical cannabis framework has barely shifted since legalisation in 2018 - The bottlenecks across cultivatio...

EP1 - CEOs Tim Kirby of Releaf and James Duckenfield of Glass Pharm sat down to discuss the ever-evolving UK medical cannabis sector. In 2024, we joined forces with Glass Pharms in the UK's largest ever medical cannabis deal, providing Releaf patients with a consistent, high-quality supply of domestic grown CBPMs. As one of the most-trusted #medicalcannabis clinics in the UK, our incredible p...